The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Controlled Protein Degradation Regulates Ribonucleotide Reductase Activity in Proliferating Mammalian Cells during the Normal Cell Cycle and in Response to DNA Damage and Replication Blocks
Open accessAbstract
Ribonucleotide reductase (RNR) plays a central role in the formation and control of the optimal levels of deoxyribonucleoside triphosphates, which are required for DNA replication and DNA repair processes. Mammalian RNRs are composed of two nonidentical subunits, proteins R1 and R2. The levels of the limiting R2 protein control overall RNR activity during the mammalian cell cycle, being undetectable in G(1) phase and increasing in S phase. We show that in proliferating mammalian cells, the transcription of the R2 gene, once activated in the beginning of S phase, reaches its maximum 6-7 h later and then declines. Surprisingly, DNA damage and replication blocks neither increase nor prolong the R2 promoter activity in S phase. Instead, the cell cycle activity of the mammalian enzyme is controlled by an S phase/DNA damage-specific stabilization of the R2 protein, which is effective until cells pass into mitosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2005) · doi:10.1128/9781555816704 · Cited by 5,683
Cited by
Nordlund, P., & Reichard, P. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142443 · Cited by 1,079
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Structure, function, and mechanism of ribonucleotide reductases
Kolberg, M., Strand, K. R., Graff, P., & Andersson, K. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.02.007 · Cited by 437
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
Aye, Y., Li, M., Long, M. J. C., & Weiss, R. S. (2015) · Oncogene · doi:10.1038/onc.2014.155 · Cited by 436
Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance
Lee, S., Kim, S. M., & Lee, R. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4322 · Cited by 433
D'Angiolella, V., Donato, V., Forrester, F. M., Jeong, Y.-T., Pellacani, C., Kudo, Y., Saraf, A., Florens, L., Washburn, M. P., & Pagano, M. (2012) · Cell · doi:10.1016/j.cell.2012.03.043 · Cited by 395
Structure and function of the radical enzyme ribonucleotide reductase
Eklund, H., Uhlin, U., Färnegårdh, M., Logan, D. T., & Nordlund, P. (2001) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(01)00014-1 · Cited by 323
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
Pfister, S. X., Markkanen, E., Jiang, Y., Sarkar, S., Woodcock, M., Orlando, G., Mavrommati, I., Pai, C.-C., Zalmas, L.-P., Drobnitzky, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.015 · Cited by 300
Håkansson, P., Hofer, A., & Thelander, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512894200 · Cited by 289
Self-citationRibonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Pyrimidine pathways in health and disease
LOFFLER, M., FAIRBANKS, L., ZAMEITAT, E., MARINAKI, A., & SIMMONDS, H. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.07.003 · Cited by 275
Simon, C. O., Holtappels, R., Tervo, H.-M., Böhm, V., Däubner, T., Oehrlein-Karpi, S. A., Kühnapfel, B., Renzaho, A., Strand, D., Podlech, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01248-06 · Cited by 182
Avval, F. Z., & Holmgren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809338200 · Cited by 169
Mazzu, Y. Z., Armenia, J., Chakraborty, G., Yoshikawa, Y., Coggins, S. A., Nandakumar, S., Gerke, T. A., Pomerantz, M. M., Qiu, X., Zhao, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4046 · Cited by 156
Yao, R., Zhang, Z., An, X., Bucci, B., Perlstein, D. L., Stubbe, J., & Huang, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131932100 · Cited by 151
Hilton, B. A., Liu, J., Cartwright, B. M., Liu, Y., Breitman, M., Wang, Y., Jones, R., Tang, H., Rusinol, A., Musich, P. R., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700014r · Cited by 52
Belletti, S., Uggeri, J., Gatti, R., Govoni, P., & Guizzardi, S. (2007) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2007.00320.x · Cited by 38
“In cycling cells, the dNTPs pool depends on the Sphase-specific enzyme ribonucleotide reductase (RNR) (31) that act in de novo synthesis (32).”
Background
Metadata
- Authors
- Chabes, A., & Thelander, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 23
- Pages
- 17747-17753
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2060455152
- Cited by
- 178
- References
- 2
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.